Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Blueberries Medical Corp. (1OA.F)

Compare
0.0030
0.0000
(0.00%)
As of 8:14:09 AM GMT+2. Market Open.
Loading Chart for 1OA.F
  • Previous Close 0.0030
  • Open 0.0030
  • Bid 0.0020 x --
  • Ask 0.0150 x --
  • Day's Range 0.0030 - 0.0030
  • 52 Week Range 0.0010 - 0.0200
  • Volume 1,500
  • Avg. Volume 249
  • Market Cap (intraday) 2.583M
  • Beta (5Y Monthly) 2.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Apr 24, 2025 - Apr 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.

blueberriesmed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1OA.F

View More

Performance Overview: 1OA.F

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

1OA.F
57.14%
S&P/TSX Composite index (^GSPTSE)
6.52%

1-Year Return

1OA.F
70.00%
S&P/TSX Composite index (^GSPTSE)
4.09%

3-Year Return

1OA.F
90.91%
S&P/TSX Composite index (^GSPTSE)
5.62%

5-Year Return

1OA.F
92.59%
S&P/TSX Composite index (^GSPTSE)
62.46%

Compare To: 1OA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1OA.F

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    2.58M

  • Enterprise Value

    2.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.19

  • Price/Book (mrq)

    1.50

  • Enterprise Value/Revenue

    14.11

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -32.18%

  • Return on Equity (ttm)

    -132.56%

  • Revenue (ttm)

    265.81k

  • Net Income Avi to Common (ttm)

    -1.14M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    251.31k

  • Total Debt/Equity (mrq)

    0.95%

  • Levered Free Cash Flow (ttm)

    -481.39k

Research Analysis: 1OA.F

View More

Company Insights: 1OA.F

Research Reports: 1OA.F

View More

People Also Watch